She credits GLP-1 receptor agonists mainly with weight loss and better metabolic health for women with PCOS and excess weight, and urges caution beyond that.
Recap by typeshit. Post by @dr_monalisa_and_her_reproneet on Instagram.
Among 208,970 matched adults with type 2 diabetes, GLP-1 starters had 0.15% new diagnoses versus 0.10% on DPP-4 drugs. Authors call it a signal needing confirmation.
Researchers used AI to identify fungal peptides that taste salty or boost saltiness, aimed at cutting sodium in food. A food science find rather than a drug story.
The 1,200-person trial starts next year with MIT and Pitt researchers, funded by a $13 million Arnold Ventures grant, and will also track housing and jobs.
Researchers found the peptide they built as a treatment already circulates in human blood, at lower levels in people with cognitive impairment.
Researchers found women who had used hormonal birth control were more likely to go on to begin semaglutide than women who never had.
Her answer: results vary from person to person and losing fat from one area isn't guaranteed, so treatment should fit individual needs.
Loading…